Logo

SANJIVANI PARANTERAL LTD. Share Price

BSE: 531569
|
Pharmaceuticals
₹ 156.00
+₹1.75 (1.13%)
1D
Last updated 03 Jul, 2026, 15:22 IST

SANJIVANI PARANTERAL LTD. Share Price Today

As of 5 Jul 2026, SANJIVANI PARANTERAL LTD. share price is ₹156.00. The stock opened at ₹154.20, compared to its previous close of ₹154.25. During today's trading session, SANJIVANI PARANTERAL LTD. share price moved in the range of ₹152.00 to ₹156.00, with an average price of ₹154.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹126.00 and a high of ₹268.80.


₹152.00
1.13% up today
₹156.00
1D LOW
1D HIGH

SANJIVANI PARANTERAL LTD. Returns Calculator

Open
₹154.20
High
₹156.00
Low
₹152.00
Prev. close
₹154.25

Circuit
L
H
₹124.00
₹185.90
52-week
L
H
₹126.00
₹268.80

SANJIVANI PARANTERAL LTD. Shareholder Returns

SANJIVANI PARANTERAL LTD. Share Price History

Mkt Cap Cr
189.49

P/E
28.30

P/B
3.93

ROE
13.87%

D/E
0.19

ROCE
16.29%

Div. Yield
0.00%

EPS(TTM)
5.67
Turnover
1.14

EV/EBITDA
17.12

Net Margin
0.00%

Op. Margin
0.00%

ROA
7.62%

Quick Ratio
0.00

Curr. Ratio
2.53
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Sanjiv.Parant. outperforming all market indices
Step 2 of 5
Valuation
Expensive
Sanjiv.Parant. PE is significantly higher than its peers
Step 1 of 5
Earnings
Very Poor
Sanjiv.Parant. revenue, operating profits and net profits have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

SANJIVANI PARANTERAL LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Revenue₹70.10₹54.41
Other Income₹1.21₹0.52
Total Revenue₹71.31₹54.93
Total Expenses₹60.96₹47.36
Profit Before Tax₹10.35₹7.57
Tax₹2.26₹1.41
Profit After Tax₹8.09₹6.17
EPS - Basic₹6.81₹5.28
EPS - Diluted₹6.81₹5.28

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Profit before tax₹10.35₹7.57
Income before WC changes₹11.08₹8.34
Change in Assets-₹12.07-₹10.59
Change in Liabilities₹14.71-₹7.34
Change in WC₹2.64-₹17.93
Cash flow from Operations₹12.40-₹10.70
Cash flow from Investing-₹21.91-₹12.21
Cash flow from Financing₹10.46₹23.16
Total Cash Flow₹0.94₹0.24
Cash (Start of the year)₹0.54₹0.30
Cash (End of the year)₹1.49₹0.54

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Non-Current Assets₹44.02₹14.77
Current Assets₹34.18₹28.64
Total Assets₹78.20₹43.41
Current Liabilities₹31.79₹13.78
Net Current Asset₹2.39₹14.86
Non-Current Liabilities₹6.53₹1.73
Equity Capital₹39.87₹27.90
Total Equity & Liabilities₹78.20₹43.41

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹70.10₹54.41₹35.49₹30.61
Other Income₹1.21₹0.52₹0.55₹0.24
Total Revenue₹71.31₹54.93₹36.05₹30.86
Total Expenses₹60.95₹47.36₹31.10₹25.98
Profit Before Tax₹10.36₹7.57₹4.94₹4.88
Tax₹2.26₹1.41₹0.43₹0.03
Profit After Tax₹8.10₹6.17₹4.51₹4.85
EPS - Basic₹6.89₹5.28₹4.51₹4.85
EPS - Diluted₹6.67₹5.28₹4.51₹4.85

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹10.36₹7.57₹4.94₹4.88
Income before WC changes₹11.09₹8.34₹5.63₹4.35
Change in Assets-₹15.90-₹10.59-₹3.15₹2.42
Change in Liabilities₹5.90-₹7.34₹2.25₹1.79
Change in WC-₹10.00-₹17.93-₹0.90₹4.22
Cash flow from Operations-₹0.24-₹10.70₹4.68₹8.52
Cash flow from Investing-₹5.81-₹12.21-₹0.99-₹0.67
Cash flow from Financing₹6.14₹23.16-₹3.73-₹7.68
Total Cash Flow₹0.09₹0.24-₹0.04₹0.17
Cash (Start of the year)₹0.54₹0.30₹0.34₹0.17
Cash (End of the year)₹0.63₹0.54₹0.30₹0.34

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹26.89₹14.77₹12.74₹10.57
Current Assets₹38.10₹28.64₹8.27₹7.73
Total Assets₹65.00₹43.41₹21.01₹18.30
Current Liabilities₹20.46₹13.78₹22.65₹21.89
Net Current Asset₹17.64₹14.86-₹14.39-₹14.17
Non-Current Liabilities₹6.53₹1.73₹1.43₹3.99
Equity Capital₹38.00₹27.90-₹3.07-₹7.58
Total Equity & Liabilities₹65.00₹43.41₹21.01₹18.30
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
154.95
1770
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 1770
Buy orders: 0%
Sell orders: 100%
Bearish
3
Neutral
3
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
55.62
Neutral

ATR (14)
8.2
Neutral

STOCH(9,6)
89.7
Bearish

STOCH RSI (14)
92.41
Bearish

ADX(9)
16.92
Bullish

UO(9)
59.32
Neutral

ROC(12)
3.99
Bullish

WillR(14)
-10.3
Bearish
Period
Simple value
Exponential vaue

5D
153.09
152.72

10D
150.91
151.22

20D
148.71
149.91

50D
151.32
152.84

100D
163.04
162.4

About SANJIVANI PARANTERAL LTD.

SANJIVANI PARANTERAL LTD. logo
ISIN
INE860D01013
Sector Market Cap
₹ 189.49 Cr

Sanjivani Paranteral Limited is engaged in the business of manufacturing pharmaceutical products. The Company’s products include oral solids, small volume parenteral and sterile powder formula. Its product category includes antibiotic, anti-emetic, non-steroidal anti-inflammatory drugs (NSAID) and analgesic, antimalarial, calcium and vitamin, sedative, steroid, cardiovascular, anti-fibrinolytic, anti-coagulant, vasoconstrictor, inotropic agent, multivitamin, nutrition, diuretic, anti-hypertensive, and others. Its anti-biotic includes Netilmicin Sulfate, Amikacin Sulfate, and Gentamycin Sulfate. Its anti-emetic includes Ranitidine Hydrochloride, Metoclopramide, Ondansetron, and Promethazine. Its NSAID and analgesic include Acetaminophen Injection and Diclofenac Sodium Injection. Its calcium and vitamins include Methylcobalamin 500 mcg/ml and Nicotinic Acid 10 mg/ml. Its sedative includes Midazolam Hydrochloride, and Diazepam. Its diuretic includes Furosemide.

SANJIVANI PARANTERAL LTD. Financial Highlights

  • Revenue: SANJIVANI PARANTERAL LTD. reported revenue of ₹69.76 crore in FY26 vs ₹71.32 crore in FY25. It showed a decrease of 2.19% on a yearly basis.
  • Operating Profit: SANJIVANI PARANTERAL LTD. reported an operating profit of ₹9.39 crore in FY26 vs ₹10.35 crore in FY25. It showed a decrease of 9.28% on a year-on-year basis.
  • Net Profit: SANJIVANI PARANTERAL LTD. reported a net profit of ₹6.69 crore in FY26 vs ₹8.09 crore in FY25. It showed a decrease of 17.31% on a yearly basis.

SANJIVANI PARANTERAL LTD. Quarterly Result Highlights

  • SANJIVANI PARANTERAL LTD. reported revenue of ₹13.81 crore in Mar 2026, compared with ₹22.36 crore in Dec 2025, representing a decrease of 38.24% on a quarter-on-quarter (QoQ) basis.
  • SANJIVANI PARANTERAL LTD. reported an operating profit of ₹1.20 crore in Mar 2026, compared with ₹3.70 crore in Dec 2025, representing a decrease of 67.57% on a quarter-on-quarter (QoQ) basis.
  • SANJIVANI PARANTERAL LTD. reported a profit of ₹0.55 crore in Mar 2026, compared with ₹2.78 crore in Dec 2025, reflecting a decrease of 80.22% on a QoQ basis.
  • The earnings per share (EPS) of SANJIVANI PARANTERAL LTD. stood at ₹6.81 during Mar 2026.
Know more
Promoters
31.26%
FII
0.00%
Other DII
6.04%
Retail and other
62.71%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
SANJIVANI PARANTERAL LTD. logo
SANJIVANI PARANTERAL LTD.
Pharmaceuticals
Add Stock
Add Another

FAQs on SANJIVANI PARANTERAL LTD. Share Price